The NFL levels in serum were reported to be a good judged biomarker on the progression of ALS disease [64], and the NFH in both CSF and/or serum also play a similar role with NFL [65], the NFH levels in both CSF and/or serum are significantly correlated with the survival of ALS patients [62]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.